申请人:ChemoCentryx, Inc.
公开号:US20140031348A1
公开(公告)日:2014-01-30
Compounds are provided that act as potent antagonists of the CCR2 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for CCR2. The compounds are generally aryl sulfonamide derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR2-mediated diseases, and as controls in assays for the identification of CCR2 antagonists.
提供了一些化合物,它们作为CCR2受体的有效拮抗剂。动物实验表明,这些化合物对于治疗CCR2的标志性疾病炎症非常有用。这些化合物通常是芳基磺酰胺衍生物,并且可用于制药组合物、治疗CCR2介导的疾病的方法以及作为CCR2拮抗剂鉴定的测定中的对照物。